FDG PET/CT to predict the curability of endoscopic resection for early gastric cancer
- 194 Downloads
We evaluated the value of fluorine-18 fluorodeoxyglucose positron-emission tomography/computed tomography (FDG PET/CT) as a complementary imaging modality to endoscopy to predict the curability of endoscopic submucosal dissection (ESD) for early gastric cancer (EGC).
The institutional review board approved this retrospective study with a waiver of informed consent. The records of patients who underwent FDG PET/CT for initial routine staging of gastric cancer from January 2012 to October 2017 were reviewed retrospectively. Among them, the patients who had EGC with well or moderately differentiated adenocarcinoma were included in this study. A total of 210 EGCs in 199 patients (mean age ± SD, 67 ± 10 years) were selected for this study. For the analysis of FDG PET/CT image, the radiotracer uptake by the primary tumor was compared with the background gastric uptake. Each case was classified as curable by ESD (no discrete radioactivity) and not curable by ESD (discrete radioactivity).
The detection rate of EGC by FDG PET/CT was 37.1% (78 discrete radioactivity in 210 EGCs). However, for the detection of EGC that is not curable by ESD, the sensitivity, specificity, positive predictive value, negative predictive value, and area under the receiver operating characteristic curve with 95% confidence intervals were 79% (67–87%), 91% (85–95%), 81% (71–88%), 89% (84–93%), and 0.85 (0.79–0.89), respectively.
FDG PET/CT may be a useful complementary imaging modality to endoscopy to predict the curability of ESD for EGC.
KeywordsEarly gastric cancer Endoscopic submucosal dissection Endoscopic resection FDG PET/CT
Compliance with ethical standards
This study was reviewed by the appropriate Ethics Committee and was, therefore, performed in accordance with the ethical standards laid down in the Declaration of Helsinki revised in Brazil 2013.
This retrospective study was waived from the need to obtain informed consent by our Institutional Review Board (KUH1280106).
Conflict of interest
Hyun Woo Chung, Jeong Hwan Kim, In-Kyung Sung, Sun-Young Lee, Hyung Seok Park, Chan Sup Shim, Ho Yoon Bang, Young So, and Eun Jeong Lee declare that they have no conflicts of interest.
- Lee EJ, Chang SH, Lee TY, Yoon SY, Cheon YK, Shim CS et al (2015) Prognostic value of FDG-PET/CT total lesion glycolysis for patients with resectable distal bile duct adenocarcinoma. Anticancer Res 35(12):6985–6991Google Scholar
- Mouri R, Yoshida S, Tanaka S, Oka S, Yoshihara M, Chayama K (2009) Usefulness of endoscopic ultrasonography in determining the depth of invasion and indication for endoscopic treatment of early gastric cancer. J Clin Gastroenterol 43(4):318–322. https://doi.org/10.1097/MCG.0b013e3181775966 CrossRefGoogle Scholar
- Park S, Ha S, Kwon HW, Kim WH, Kim TY, Oh DY et al (2017) Prospective evaluation of changes in tumor size and tumor metabolism in patients with advanced gastric cancer undergoing chemotherapy: association and clinical implication. J Nucl Med 58(6):899–904. https://doi.org/10.2967/jnumed.116.182675 CrossRefGoogle Scholar
- Uedo N, Fujishiro M, Goda K, Hirasawa D, Kawahara Y, Lee JH et al (2011) Role of narrow band imaging for diagnosis of early-stage esophagogastric cancer: current consensus of experienced endoscopists in asia-pacific region. Dig Endosc 23(Suppl 1):58–71. https://doi.org/10.1111/j.1443-1661.2011.01119.x CrossRefGoogle Scholar